Nine Masts Capital »

Proqr Thrapeutics N V shs euro shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $48k 30k 1.62

More positions owned by Nine Masts Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Alphabet Cap Stk Cl C (GOOG)
Warner Bros Discovery Com Ser A (WBD)
Silicon Laboratories (SLAB)
Hdfc Bank Sponsored Ads (HDB)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Norfolk Southern (NSC)
Clearwater Analytics Hldgs I Cl A (CWAN)
Webster Financial Corporation (WBS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hologic
Nio Note 4.625%10/1 (Principal)
Ase Technology Hldg Sponsored Ads (ASX)

View all positions for Nine Masts Capital

Top funds holding Proqr Thrapeutics N V shs euro

Adage Capital Partners GP
Privium Fund Management B.V.
Standard Life Aberdeen
Affinity Asset Advisors
Sio Capital Management
DAFNA Capital Management
Kynam Capital Management
Ikarian Capital
Morgan Stanley
Platinum Investment Mangement
M28 Capital Management
Two Sigma Investments
Point72 Asset Management
Citadel Advisors
Nomura Asset Management International

View all funds holding Proqr Thrapeutics N V shs euro